Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies. 

Boston Scientific has received U.S. Food and Drug Administration (FDA) approval for its Agent Drug-Coated Balloon (DCB) for the treatment of coronary in-stent restenosis (ISR) in patients with coronary artery disease.

FDA approves Boston Scientific’s new drug-coated balloon for coronary in-stent restenosis

Interventional cardiologists have been anticipating this news for quite some time. The device, the first of its kind, provides an alternative treatment option to repeat PCI or cardiac surgery for patients with coronary ISR.

Department of Justice DOJ

DOJ collects $1.9B from healthcare in 2023, with imaging provider making 1 of the biggest payouts

Cardiac Imaging Inc. agreed to pay $85 million in October, the largest judgment in the “Laboratory, Pathology, Radiology and Diagnostics" category. 

Biosense Webster gained CE mark approval for its Varipulse pulsed field ablation (PFA) system in Europe

Biosense Webster gains CE mark approval for new PFA system

The news represents yet another big regulatory approval for PFA technology in 2024. Could FDA approval be next for Biosense Webster?

money cybersecurity ransomware health IT data breach hacker

Change Healthcare cyberattack having an ‘alarming’ impact on physician practices, advocates warn HHS

Since the issue arose on Feb. 21, providers in radiology and other specialties have experienced “substantial” billing and cash flow disruptions, MGMA reported Wednesday. 

Thumbnail

Court upholds decision to strip radiologist of license for performing cosmetic surgeries

Wade Banker, MD, disputes the allegations and is appealing the ruling.

Thumbnail

Lawsuit accuses radiology AI vendor MIM Software of patent theft

Progenics Pharmaceuticals Inc. claims MIM stole its patents and used them to help entice GE HealthCare to buy the company in January.  

BioZorb 3D bioabsorbable marker Hologic

Hologic breast care devices could cause life-threatening complications, FDA warns

UPDATED: BioZorb is FDA cleared for the radiographic marking of soft tissue sites for future procedures such as radiation therapy. 

Thumbnail

Dozens of Indigenous Canadians file lawsuit against two radiologists over undisclosed study

The plaintiffs claim they were imaged for a liver disease study without giving their consent, or learning of the results.